Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitors for cancer therapy. (October 2020) - Miles, D.; Chen, Y.; Paprcka, S.L.; Foley, C.N.; Grange, R.; Leleti, M.R.; Zhao, X.; Jin, L.; Young, S.W.; Walters, M.J.; Powers, J.P.